Navigation Links
Chipscreen Biosciences and HUYA Bioscience Int'l Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer
Date:10/23/2008

First Compound Sourced from China Shows Strong Results Presented at

Cambridge Healthtech Institute Fall Conference

BOSTON, Oct. 23 /PRNewswire/ -- CHI -- Chipscreen Biosciences (Chipscreen) and HUYA Bioscience International (HUYA) today described the preclinical profile and outcome of a Phase I trial with Chidamide/HBI-8000, carried out in China by Chipscreen Biosciences, Ltd. of Shenzhen. The clinical trial produced best in class pharmacokinetics (PK), biomarker and safety profiles, and demonstrated activity against T-lymphoma and other tumor types.

The compound, known as Chidamide in China and HBI-8000 in the US, is a novel, benzamide class histone deacetylase (HDAC) inhibitor discovered by Chipscreen using a computer-aided rationale design approach. Chidamide/HBI-8000 shows promise for the treatment of a broad range of cancers. The Phase I trial, which was initiated in China in April 2007, evaluated safety, PK, biomarker and efficacy profiles in relapsed/refractory solid tumors and lymphomas.

"The preclinical data, generated in both China and the US, as well as the Phase I results are very promising -- demonstrating a best in class profile," said Mireille Gingras, PhD, CEO, HUYA Bioscience International. "The data will enable advancement of Chidamide/HBI-8000 to Phase II/III studies in China and Phase I in the US, and provides significant validation of our China/US co-development business model."

"With this exciting data in humans and continuing research efforts in our laboratory, we are also starting to understand better the unique properties and novel molecular mechanisms of action potentially associated with Chidamide as well as certain subtypes of the HDAC family," said Xian-Ping LU, PhD, President and Chief Scientific Officer of Chipscreen Biosciences.

HUYA holds exclusive development and commercialization rights to the compound worldwide outside of China, while Chipscreen maintains rights in China.
'/>"/>

SOURCE HUYA Bioscience International; Chipscreen Biosciences
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
4. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
5. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
6. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
7. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
8. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
9. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , February 27, 2015 ... new study showing you trends, R&D progress, and predicted ... heading? What are the commercial prospects for this ... you potential revenues and other trends to 2025, discussing ... report lets you assess regenerative medicine : cell-based ...
(Date:2/27/2015)... 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") ... financial results for its first quarter ended December 31, ... December 31, 2014, revenue was $1,336,685. Operating expenses were ... $0.02 per share.  Covalon,s President and ... pleased with the significant progress we have made over ...
(Date:2/27/2015)... , February 27, 2015 ... sein bahnbrechendes Überwachungssystem für kongestive Herzinsuffizienz (CHF) ... -     ... die ein neuartiges Herzüberwachungssystem für Patienten mit ... bekannt, dass sie ein Finanzierungsvorhaben über 5 ...
Breaking Medicine Technology:Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2
... 7, 2011 Reportlinker.com announces that a ... its catalogue: Global Microscopes ... This report analyzes the worldwide ... the following Product Segments: Optical Microscopes, Charged ...
... Dec. 7, 2011 Verinata Health, Inc., a privately-held ... the relocation of its corporate headquarters and laboratory operations ... "Our move to a much larger and state-of-the ... appropriately prepare for the growth and expansion expected with ...
Cached Medicine Technology:Global Microscopes Industry 2Verinata Health Announces New Corporate Headquarters and Expanded Laboratory Operations 2
(Date:2/28/2015)... (PRWEB) February 28, 2015 For those ... in person, the Mesothelioma Applied Research Foundation ... on Tuesday, March 3, starting at 9:30 AM. , ... no registration. The broadcast can be accessed through any ... http://www.curemeso.org/symposium . , The Symposium is a unique event ...
(Date:2/28/2015)... FL (PRWEB) February 28, 2015 ... organization has sponsored visitor health insurance programs for visitors ... years. Most Indian elderly parents traveling to the United ... such as diabetes and blood pressure. These diseases are ... not even list them as medical conditions. There were ...
(Date:2/28/2015)... Toronto, ON (PRWEB) February 28, 2015 ... pleased to announce that they have officially relaunched their ... only more user-friendly, but it contains a new section ... have access to read the full biographies of each ... updated portion of the website was designed to provide ...
(Date:2/28/2015)... Viejo, California (PRWEB) February 28, 2015 ... release of TransFold Volume 2. A fully customizable ... X. , “TransFold Volume 2 gives users total control ... said Christina Austin, CEO of Pixel Film Studios. “TransFold ... Pro X editor.” , TransFold Volume 2 from Pixel ...
(Date:2/27/2015)... February 27, 2015 Hispanics develop alcoholic ... between four and 12 years earlier than Whites/Caucasians or ... Davis Health System. , While previous research indicated that ... populations, the new study -- published online in the ... to be the first to pinpoint racial and ethnic ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans 2
... Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord ... ) focused on bringing the life saving potential ... it has received a commitment for up to $2.3 million ... storage of multiple stem cell products including umbilical cord blood ...
... -- Domain Registration Corp.,(OTC Bulletin Board: DOMR), today ... all of the outstanding capital stock of China ... Islands corporation, and the,Board of Directors has adopted ... Asia, Inc.", which shall become effective upon shareholder,approval ...
... endocrinologist Richard Sherbahn, MD, at the Advanced Fertility Center of Chicago ... eggs retrieved -- but not a correspondingly higher rate of success ... ... May 14, 2009 -- Infertility specialist Richard Sherbahn, MD , ...
... outpatient appointment calendar and call schedule to its popular ... pMDsoft for BlackBerry. pMDsoft lowers the cost of ... with patients, and now allows a practice to take ... allow pMDsoft to act as a mobile extension of ...
... other HIT solutions can use CPMRC,s interdisciplinary clinical content through TSG,s ... ... May 14, 2009 -- CPM Resource Center (CPMRC) and ... and medium-sized hospitals with next-generation nursing and interdisciplinary documentation that integrates ...
... Companion C7 Dragonfly(TM) Imaging Catheter Strengthen LightLab,s Market ... the pioneer and leader in the development of ... applications, today announced the launch of its next-generation ... C7 Dragonfly Imaging Catheter, at EuroPCR 2009, Barcelona, ...
Cached Medicine News:Health News:Cord Blood America Receives Commitment for $2.3 Million to Fund Its Own Stem Cell Laboratory 2Health News:Domain Registration Corp Successfully Completes Reverse Merger 2Health News:Domain Registration Corp Successfully Completes Reverse Merger 3Health News:Domain Registration Corp Successfully Completes Reverse Merger 4Health News:Chicago-area Infertility Specialist Richard Sherbahn, MD, Reports a Woman's Body Mass Index Affects Her Success in Infertility Treatment 2Health News:Chicago-area Infertility Specialist Richard Sherbahn, MD, Reports a Woman's Body Mass Index Affects Her Success in Infertility Treatment 3Health News:Chicago-area Infertility Specialist Richard Sherbahn, MD, Reports a Woman's Body Mass Index Affects Her Success in Infertility Treatment 4Health News:pMDsoft Adds Mobile Appointment Calendar to iPhone Charge Capture Software 2Health News:pMDsoft Adds Mobile Appointment Calendar to iPhone Charge Capture Software 3Health News:pMDsoft Adds Mobile Appointment Calendar to iPhone Charge Capture Software 4Health News:CPM Resource Center and The Shams Group Partner to Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems 2Health News:CPM Resource Center and The Shams Group Partner to Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems 3Health News:CPM Resource Center and The Shams Group Partner to Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems 4Health News:LightLab Imaging Introduces World's Highest Resolution OCT System for Intracoronary Imaging at EuroPCR 2009 2
... Finnpipette Digital Multichannel, with it's ... work of routine laboratory tasks. ... advanced features: Soft-touch tip ejection, ... pipetting (0.5-10ul models), Entire pipette ...
... ergonomics, and value!, Comfortable feel and ... handle , Finer control while pipetting with ... tip ejection with long, lever tip ejector ... sterilization without the need for recalibration , ...
... The Finnpipette Digital Multichannel, with ... lighter work of routine laboratory ... these advanced features: Soft-touch tip ... volume pipetting (0.5-10ul models), Entire ...
... Easy to operate in a wide variety of ... • The manifold can be freely rotated against ... yet always at an optimum angle towards the ... permits the use of most common pipette tips, ...
Medicine Products: